Zobrazeno 1 - 10
of 1 375
pro vyhledávání: '"S. Gidding"'
Autor:
Laney K. Jones, PharmD, MPH, Gemme Campbell-Salome, PhD, Nicole L. Walters, BS, Andrew Brangan, BS, Kelly M. Morgan, MS, Eric P. Tricou, MS, Zoe T. Lindsey Mills, BS, Mary P. McGowan, MD, Samuel S. Gidding, MD, Alicia M. Johns, PhD, H. Lester Kirchner, PhD, Alanna Kulchak Rahm, PhD, Amy C. Sturm, MS
Publikováno v:
JACC: Advances, Vol 3, Iss 9, Pp 101198- (2024)
Background: Relatives of probands diagnosed with familial hypercholesterolemia (FH) should undergo cascade testing for FH. Objectives: The purpose of this study was to evaluate probands’ choices of innovative strategies to communicate their FH resu
Externí odkaz:
https://doaj.org/article/783b7d5f51a54c71b4cd5f9ef467d74a
Autor:
Samuel S. Gidding
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 6 (2024)
Externí odkaz:
https://doaj.org/article/d45c4ffae56d48dea5d4d87a238408ca
Autor:
Jeanie B. Tryggestad, Megan M. Kelsey, Kimberly L. Drews, Shirley Zhou, Nancy Chang, Elia Escaname, Samuel S. Gidding, Elvira Isganaitis, Siripoom McKay, Rachana Shah, Michelle Van Name
Publikováno v:
Children, Vol 11, Iss 6, p 630 (2024)
Diabetes exposure during pregnancy affects health outcomes in offspring; however, little is known about in utero exposure to preexisting parental youth-onset type 2 diabetes. Offspring born to participants during the Treatment Options for Type 2 Diab
Externí odkaz:
https://doaj.org/article/3e2110d20979459aaafd3ad8c2f717c7
Autor:
Samuel S. Gidding, Christie M. Ballantyne, Marina Cuchel, Sarah de Ferranti, Lisa Hudgins, Allison Jamison, Mary P. McGowan, Amy L. Peterson, Robert D. Steiner, Melissa K. Uveges, Yunshu Wang
Publikováno v:
Global Heart, Vol 19, Iss 1, Pp 43-43 (2024)
Homozygous familial hypercholesterolemia (HoFH) is an ultra-rare inherited condition that affects approximately one in 300,000 people. The disorder is characterized by extremely high, life-threatening levels of low-density lipoprotein (LDL) cholester
Externí odkaz:
https://doaj.org/article/d2058999a0ea4372bd20514d6dc45bef
Autor:
Samuel S. Gidding, H. Lester Kirchner, Andrew Brangan, William Howard, Melissa A. Kelly, Kelly D. Myers, Kelly M. Morgan, Matthew T. Oetjens, Timothy C. Shuey, David Staszak, Natasha T. Strande, Nicole L. Walters, Kristen D. Yu, Katherine A. Wilemon, Marc S. Williams, Amy C. Sturm, Laney K. Jones
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 13 (2023)
Background Data mining of electronic health records to identify patients suspected of familial hypercholesterolemia (FH) has been limited by absence of both phenotypic and genomic data in the same cohort. Methods and Results Using the Geisinger MyCod
Externí odkaz:
https://doaj.org/article/05b8f792bfdd43bc923992cd079ffc47
Autor:
Gerald F. Watts, Laney K. Jones, Mitchell N. Sarkies, Jing Pang, Samuel S. Gidding, Peter Libby, Raul D. Santos
Publikováno v:
Global Heart, Vol 19, Iss 1, Pp 12-12 (2024)
Familial hypercholesterolaemia (FH), a common monogenic disorder, is a preventable cause of premature coronary artery disease and death. Up to 35 million people worldwide have FH, but most remain undetected and undertreated. Several clinical guidelin
Externí odkaz:
https://doaj.org/article/84503b15545f4aeebd5334ee42942993
Autor:
Marina Cuchel, Paul C. Lee, Lisa C. Hudgins, P. Barton Duell, Zahid Ahmad, Seth J. Baum, MacRae F. Linton, Sarah D. de Ferranti, Christie M. Ballantyne, John A. Larry, Linda C. Hemphill, Iris Kindt, Samuel S. Gidding, Seth S. Martin, Patrick M. Moriarty, Paul P. Thompson, James A. Underberg, John R. Guyton, Rolf L. Andersen, David J. Whellan, Irwin Benuck, John P. Kane, Kelly Myers, William Howard, David Staszak, Allison Jamison, Mary C. Card, Mafalda Bourbon, Joana R. Chora, Daniel J. Rader, Joshua W. Knowles, Katherine Wilemon, Mary P. McGowan
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 9 (2023)
Background Homozygous familial hypercholesterolemia (HoFH) is a rare, treatment‐resistant disorder characterized by early‐onset atherosclerotic and aortic valvular cardiovascular disease if left untreated. Contemporary information on HoFH in the
Externí odkaz:
https://doaj.org/article/9dcee4a6f1ed4758895b21e17b75e550
Autor:
Kausik K. Ray, Brian A. Ference, Tania Séverin, Dirk Blom, Stephen J. Nicholls, Mariko H. Shiba, Wael Almahmeed, Rodrigo Alonso, Magdalena Daccord, Marat Ezhov, Rosa Fernández Olmo, Piotr Jankowski, Fernando Lanas, Roopa Mehta, Raman Puri, Nathan D. Wong, David Wood, Dong Zhao, Samuel S. Gidding, Salim S. Virani, Donald Lloyd-Jones, Fausto Pinto, Pablo Perel, Raul D. Santos
Publikováno v:
Global Heart, Vol 17, Iss 1 (2022)
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumul
Externí odkaz:
https://doaj.org/article/d76f2dee03ca4cf1b6165d59d556f094
Autor:
Laney K. Jones, Stephanie Tilberry, Christina Gregor, Lauren H. Yaeger, Yirui Hu, Amy C. Sturm, Terry L. Seaton, Thomas J. Waltz, Alanna K. Rahm, Anne Goldberg, Ross C. Brownson, Samuel S. Gidding, Marc S. Williams, Michael R. Gionfriddo
Publikováno v:
Implementation Science, Vol 16, Iss 1, Pp 1-15 (2021)
Abstract Background Numerous implementation strategies to improve utilization of statins in patients with hypercholesterolemia have been utilized, with varying degrees of success. The aim of this systematic review is to determine the state of evidenc
Externí odkaz:
https://doaj.org/article/476ddb071f614dcea8d147ecc5b30808
Autor:
Kuller L
Publikováno v:
Epidemiology (Cambridge, Mass.) [Epidemiology] 2008 Jan; Vol. 19 (1), pp. 27-9.